STOCK TITAN

Forte Biosciences: MPM BioImpact reports 0% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Forte Biosciences, Inc. (FBRX) reports that MPM BioImpact LLC beneficially owned 0 shares of its common stock, or 0%, as of September 30, 2026. MPM BioImpact reported no sole or shared voting or dispositive power over the shares. The amendment identifies MPM BioImpact as an investment adviser and states ownership of 5% or less of the class.

Beneficial ownership 0 shares MPM BioImpact LLC's reported ownership of Forte Biosciences common stock as of September 30, 2026
Percent of class 0% MPM BioImpact LLC's reported ownership of Forte Biosciences common stock
beneficially owned technical
"Amount beneficially owned: 0"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole Voting Power technical
"Sole Voting Power 0.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Shared Dispositive Power technical
"Shared Dispositive Power 0.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many FBRX shares did MPM BioImpact report owning?

MPM BioImpact LLC reported beneficial ownership of 0 shares of Forte Biosciences common stock, representing 0% of the class, as of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





34962G208

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



MPM BioImpact LLC
Signature:Christopher Wolf
Name/Title:Chief Financial Officer
Date:11/13/2026

Keep reading